Rehabilitation and exoskeletons
Wearable and clinic robots for gait, arm, and hand rehabilitation. 7 companies reviewed across 2 subcategories.
Exoskeletons and gait rehabilitation 5
Exoskeletons and gait trainers used in clinics and at home.
6.6/10Cyberdyne review
Japanese maker of the HAL wearable cyborg, rented to rehab hospitals and clinics in more than 20 countries, with about $25 million in yearly revenue.
Strongest: Product maturity 8.5
6.3/10Lifeward review
ReWalk personal exoskeletons and AlterG anti-gravity treadmills for rehabilitation, with $22.0 million in 2025 revenue.
Strongest: Product maturity 8.0
6.1/10Tyromotion review
Graz maker of Lexo gait trainer and Amadeo, Diego and Pablo rehab devices, EUR15.6M (about $18M) revenue.
Strongest: Product maturity 7.5
5.9/10Wandercraft review
Self-balancing exoskeletons for rehabilitation and home use, now with Ekso Bionics, deployed in more than 700 rehabilitation centers.
Strongest: Product maturity 7.0
5.8/10Hocoma review
Swiss maker of the Lokomat gait robot, in a court-supervised debt moratorium until April 2027.
Strongest: Product maturity 9.0
Upper-limb rehabilitation devices 2
Powered braces and brain-computer interface devices for arm and hand recovery.
7.0/10Myomo review
A powered, muscle-signal-controlled arm brace for people with paralysis after stroke or nerve injury.
Strongest: Product maturity 8.0
6.1/10Kandu review
Van Nuys stroke-recovery company behind IpsiHand BCI therapy; LeadIQ estimates $10M-$25M revenue after Neurolutions merger.
Strongest: Product maturity 7.5